Of interest, DOT1L was recently shown to methylate non-histone proteins like the androgen receptor through recruitment of the PRNCR1 long non-coding RNA for subsequent activation of this receptor in prostate cancer after looping between enhancer and promoter sequences [68]. Here, DOT1L is linked to prostate cancer.